Researchers develop a novel plasma proteome-based test for early detection of multiple cancers, achieving high accuracy in identifying low-abundance protein biomarkers.
Researchers examined the prevalence and predictors of long coronavirus disease (COVID) in a sample representing a Washington, DC University staff in the United States of America (USA).
Researchers gathered patient’s patients’ self-reported data about the coronavirus disease 2019 (COVID-19) pandemic from across the United States of America (USA).
Researchers developed a multi-omics-based microsampling workflow for profiling proteins, metabolites, lipids, and specific cytokines and hormones, i.e., multiple analytes, in a single blood sample of 10 μl (microsample).